Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Effectiveness of rotavirus vaccination in Spain.

Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, Martinón Sánchez JM; ROTACOST research team.

Hum Vaccin. 2011 Jul;7(7):757-61. doi: 10.4161/hv.7.7.15576. Epub 2011 Jul 1.

PMID:
21521947
2.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
3.

Real-world impact of rotavirus vaccination.

Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5. doi: 10.1097/INF.0b013e3181fefa1f. Review. No abstract available.

PMID:
21183833
4.

Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.

Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD.

Expert Rev Vaccines. 2014 Mar;13(3):365-76. doi: 10.1586/14760584.2014.877846. Epub 2014 Jan 6. Review.

PMID:
24392657
5.

Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.

Bresee JS, Hummelman E, Nelson EA, Glass RI.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S1-5. Review. No abstract available.

PMID:
16088790
6.

[Rotavirus vaccination in Europe in 2010].

Grimprel E.

Bull Acad Natl Med. 2010 Nov;194(8):1451-62; discussion 1462-4. Review. French.

PMID:
22046709
7.

Rotavirus vaccination in Europe: the time has finally arrived.

Parashar UD, Glass RI.

J Pediatr Gastroenterol Nutr. 2008 May;46 Suppl 2:S21-3. doi: 10.1097/MPG.0b013e31816f77b9. Review. No abstract available.

PMID:
18460968
8.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
9.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1. Review.

10.

Rotavirus vaccines: development, current issues and future prospects.

Cunliffe NA, Bresee JS, Hart CA.

J Infect. 2002 Jul;45(1):1-9. Review.

PMID:
12217724
11.

Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea.

Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD.

J Infect Dis. 2017 Jun 1;215(11):1666-1672. doi: 10.1093/infdis/jix186. Review.

PMID:
28430997
12.

Rotavirus vaccines: recent developments and future considerations.

Angel J, Franco MA, Greenberg HB.

Nat Rev Microbiol. 2007 Jul;5(7):529-39. Review.

PMID:
17571094
13.

Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review.

Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM.

Mem Inst Oswaldo Cruz. 2011 Dec;106(8):907-11. Review.

14.

Rotavirus vaccination in Europe: drivers and barriers.

Parez N, Giaquinto C, Du Roure C, Martinon-Torres F, Spoulou V, Van Damme P, Vesikari T.

Lancet Infect Dis. 2014 May;14(5):416-25. doi: 10.1016/S1473-3099(14)70035-0. Review.

PMID:
24758998
15.

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S56-60. doi: 10.1097/INF.0b013e3181fefdc0. Review.

PMID:
21183842
16.

Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk.

Buttery JP, Standish J, Bines JE.

Pediatr Infect Dis J. 2014 Jul;33(7):772-3. doi: 10.1097/INF.0000000000000359. Review. No abstract available.

PMID:
24732449
17.

Impact of vaccination on the molecular epidemiology and evolution of group A rotaviruses in Latin America and factors affecting vaccine efficacy.

Bucardo F, Nordgren J.

Infect Genet Evol. 2015 Aug;34:106-13. doi: 10.1016/j.meegid.2015.06.013. Epub 2015 Jun 12. Review.

PMID:
26079278
18.

Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa.

O'Ryan M, Giaquinto C, Benninghoff B.

Expert Rev Vaccines. 2015;14(8):1099-112. doi: 10.1586/14760584.2015.1059282. Epub 2015 Jun 22. Review.

PMID:
26098566
19.

Economic and psychosocial impact of rotavirus infection in Spain: a literature review.

Álvarez Aldeán J, Aristegui J, López-Belmonte JL, Pedrós M, Sicilia JG.

Vaccine. 2014 Jun 24;32(30):3740-51. doi: 10.1016/j.vaccine.2014.04.058. Epub 2014 May 14. Review.

PMID:
24837768
20.

Options for improving effectiveness of rotavirus vaccines in developing countries.

Tissera MS, Cowley D, Bogdanovic-Sakran N, Hutton ML, Lyras D, Kirkwood CD, Buttery JP.

Hum Vaccin Immunother. 2017 Apr 3;13(4):921-927. doi: 10.1080/21645515.2016.1252493. Epub 2016 Nov 11. Review.

Supplemental Content

Support Center